Labcorp and Hawthorne Health Collaborate to Bring Clinical Trials Directly to Patients and Investigators in Local Communities

Labcorp, a global leader of innovative and comprehensive laboratory services, and Hawthorne Health, Inc., a complete clinical trials solution integrating technology, are pleased to announce a strategic collaboration to advance decentralized clinical trial capabilities for pharma, biotech and medical device sponsors seeking to increase patient diversity and inclusion, decrease site burden, and accelerate enrollment and clinical study timelines.

Through the collaboration, Labcorp and Hawthorne Health aim to combine their services and create new, differentiated service offerings to support decentralized clinical trials. Hawthorne Health's comprehensive digital platform allows complex study visits and clinical data collection to be conducted seamlessly in the patient home or community and has been demonstrated to increase diverse patient participation, improve quality, completeness and timeliness of trial data, and accelerate trial timelines.

At Labcorp, we are committed to making life-saving clinical trials more accessible, diverse and inclusive to all communities. Through this collaboration, we look forward to combining Labcorp's global laboratory network and logistics capabilities with Hawthorne Health's digital platform to advance our decentralized clinical trial capabilities, increase clinical trial accessibility and diversity, and bring greater value to patients, their physicians and our sponsors.

Jonathan DiVincenzo, President of Central Laboratories and International, Labcorp

The combined expertise of both Labcorp and Hawthorne Health will allow clinical trials to operate more efficiently with greater patient access and higher levels of compliance, resulting in timeline acceleration for customers. These advancements highlight our shared commitment to improving health across the globe.

Jodi Akin, Founder, Hawthorne Health

About Labcorp

Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about Labcorp at www.Labcorp.com.

SOURCE Laboratory Corporation of America Holdings